OncoTalks | Oncology Insights at Your Fingertips Titelbild

OncoTalks | Oncology Insights at Your Fingertips

OncoTalks | Oncology Insights at Your Fingertips

Von: Ontada Learn
Jetzt kostenlos hören, ohne Abo

Über diesen Titel

OncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn and community oncologists from The US Oncology Network as they explore oncology with a focus on the latest breakthroughs in cancer care. Expect concise, impactful discussions with practical clinical insights tailored for the real-world community oncology setting.

Additionally, don’t miss OncoTalks Case Journeys, where experts deep dive into oncology patient cases and treatment journeys. Join as they conduct comprehensive case reviews, explore key learnings, and discuss the latest research and advances related to each case.

Tune into OncoTalks and start unlocking pathways to better patient care today!

© 2025 Ontada All rights reserved Hygiene & gesundes Leben
Folgen
  • From Guidelines to Practice: Navigating Biomarker Testing in NSCLC

    From Guidelines to Practice: Navigating Biomarker Testing in NSCLC
    Feb 6 2026

    In this episode of OncoTalks, host Dr. Ira Zackon is joined by Dr. Alexander Spira to discuss comprehensive biomarker testing in non-small cell lung cancer (NSCLC). They unpack key findings from a recent study revealing variability in testing practices and emphasize the importance of comprehensive DNA- and RNA-based next-generation sequencing over single-gene testing. Tune in to review the latest clinical guidelines, learn how testing impacts treatment sequencing, and glean insights into how community oncology practices can overcome barriers to ensure that all NSCLC patients receive guideline-concordant testing and treatment.

    Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.
    Mehr anzeigen Weniger anzeigen
    7 Min.
  • Micro-Series | Part 4 | Future Opportunities to Personalize Multiple Myeloma Care

    Micro-Series | Part 4 | Future Opportunities to Personalize Multiple Myeloma Care
    Dec 29 2025

    This episode is part of the Micro-Series, Multiple Myeloma in 2025: Transformative Progress, the Latest Innovation, and Future Opportunities.

    In the final episode of this four-part series, Dr. Mohit Narang looks ahead to emerging innovations in multiple myeloma. Learn about new therapeutic targets, MRD testing, sequencing strategies, and personalized approaches that aim to optimize outcomes and bring us closer to functional cures.

    Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.
    Mehr anzeigen Weniger anzeigen
    4 Min.
  • Micro-Series | Part 3 | Real-World Integration of Novel Multiple Myeloma Therapies

    Micro-Series | Part 3 | Real-World Integration of Novel Multiple Myeloma Therapies
    Dec 29 2025

    This episode is part of the Micro-Series, Multiple Myeloma in 2025: Transformative Progress, the Latest Innovation, and Future Opportunities.

    In part three of four, Dr. Mohit Narang explores how bispecific antibodies and other advanced treatments are being implemented in real-world community oncology practices. Discover the operational challenges, safety considerations, and strategies that enable community oncology centers to expand access to these transformative therapies for the broader patient population.

    Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.
    Mehr anzeigen Weniger anzeigen
    6 Min.
Noch keine Rezensionen vorhanden